Loading...

PE anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M170_PE_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_CD11b_Antibody_IHC_031413
    Fixed whole mount mouse spleen was stained with Alexa Fluor® 488 F4/80 (red) (clone BM8), Brilliant Violet 421™ CD3ε (green) (clone 145-2C11), and PE CD11b (blue) (clone M1/70). Isotype controls at the same concentrations were used for the negative control. Cells were mounted in Prolong Gold and imaged with a Leica SP8 confocal. Image courtesy of Grzegorz Chodaczek and Zbigniew Mikulski at LIAI.
Compare all formats See PE spectral data See more IHC data...
Cat # Size Price Quantity Check Availability Save
101207 50 µg 45€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101208 200 µg 139€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/mL
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
  2. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  3. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  4. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  5. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  6. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  7. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  8. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  9. Hu K, et al. 2022. J Extracell Vesicles. 11:e12199. PubMed
  10. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  11. Chida J, et al. 2020. PLoS Pathog. 16:e1008823. PubMed
  12. Guo Y, et al. 2021. Exp Ther Med. 353:21. PubMed
  13. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  14. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  15. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  16. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  17. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  18. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  19. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  20. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  21. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  22. Yan F, et al. 2022. Cancer Discov. 12:792. PubMed
  23. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  24. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  25. Deng Y, et al. 2021. Acta Pharmacol Sin. 42:149. PubMed
  26. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  27. Lei G, et al. 2016. Antimicrob Agents Chemother. 60: 1289 - 1297. PubMed
  28. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  29. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  30. Xiao X, et al. 2020. J Hematol Oncol. 0.597222222. PubMed
  31. Elkabets M, et al. 2009. J Immunol. 182:4874. PubMed
  32. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  33. Conforti A, et al. 2021. PLoS One. 16:e0259894. PubMed
  34. Götz P, et al. 2022. Int J Mol Sci. 23:. PubMed
  35. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  36. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  37. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  38. Dumas SJ, et al. 2021. STAR Protocols. 2(3):100523. PubMed
  39. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  40. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  41. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  42. Llewellyn GN, et al. 2018. J Neurovirol. 24:192. PubMed
  43. Sun Y et al. 2018. Cancer cell. 34(4):643-658 . PubMed
  44. Shears RK, et al. 2020. J Allergy Clin Immunol. 145:1272. PubMed
  45. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  46. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
  47. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  48. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  49. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  50. Jard T, et al. 2020. Cell Stem Cell. 27(4):646-662.e7. PubMed
  51. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
  52. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  53. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  54. Turkowski K, et al. 2017. Glia. 10.1002/glia.23234. PubMed
  55. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  56. Hengyou Weng et al. 2018. Cell stem cell. 22(2):191-205 . PubMed
  57. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  58. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  59. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  60. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  61. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  62. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  63. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  64. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  65. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  66. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  67. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  68. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  69. Price J, et al. 2015. Diabetes. 64: 3521 - 3531. PubMed
  70. Kalucka J, et al. 2020. Cell. 764:180. PubMed
  71. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  72. Paraiso HC, et al. 2018. J Neuroinflammation. 0.694444444. PubMed
  73. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  74. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  75. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  76. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  77. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  78. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  79. Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
  80. Trenevska I, et al. 2021. PLoS One. 16:e0249967. PubMed
  81. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  82. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  83. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  84. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  85. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  86. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  87. Huang L, et al. 2016. J Biol Chem. 291: 6232 - 6244. PubMed
  88. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  89. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  90. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  91. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  92. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  93. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  94. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  95. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  96. Nakaya M, et al. 2017. J Clin Invest. 127:383. PubMed
  97. Mayo L, et al. 2008. J Immunol. 181:92. PubMed
  98. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  99. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  100. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  101. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  102. Zhang X, et al. 2022. Cells. 11:. PubMed
  103. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  104. Donley DW, et al. 2021. PLOS ONE. 16(5):e0250606. PubMed
  105. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  106. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  107. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  108. Keshavarz M, et al. 2020. Virol J. 17:64. PubMed
  109. He L, et al. 2019. iScience. 0.790972222. PubMed
  110. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  111. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  112. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  113. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  114. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  115. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  116. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  117. Jin R, et al. 2020. Mol Cancer Ther. . PubMed
  118. Nguyen TKT, et al. 2020. Am J Pathol. 286:190. PubMed
  119. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  120. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  121. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  122. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  123. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  124. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  125. Hildebrand KM, et al. 2021. PLoS One. 16:e0253864. PubMed
  126. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  127. Malekghasemi S, et al. 2020. Cell Biol Int. 44:2031. PubMed
  128. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  129. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  130. Li L, et al. 2015. J Am Soc Nephrol. 26: 2183-2197. PubMed
  131. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  132. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  133. Luong-Gardiol N, et al. 2019. Cancer Cell. 35:649. PubMed
  134. Murray C, et al. 2018. Lab Chip. 18:2396. PubMed
  135. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  136. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  137. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  138. Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
  139. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  140. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  141. Nguyen GT, et al. 2021. iScience. 24(8):102871. PubMed
  142. Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed
  143. Cao DY, et al. 2020. J Biol Chem. 295:1369. PubMed
  144. Moorlag SJCFM, et al. 2020. Cell Rep. 33:108387. PubMed
  145. Koshida R, et al. 2015. Biochem Biophys Res Commun. 463: 109-115. PubMed
  146. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  147. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  148. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  149. He J, et al. 2019. J Clin Invest. 130. PubMed
  150. Huang Y, et al. 2019. Cancer Cell. 35:677. PubMed
  151. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  152. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  153. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  154. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  155. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  156. Yang Y, et al. 2022. Elife. 11:. PubMed
  157. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23:. PubMed
  158. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  159. Kan X, et al. 2015. Cardiovasc Res. 10.1093/cvr/cvv255. PubMed
  160. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  161. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  162. Staschke K, et al. 2009. J Immunol. 183:568. PubMed
  163. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  164. Minuesa G, et al. 2019. Nat Commun. 10:2691. PubMed
  165. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  166. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  167. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  168. Perez-Garcia CG, et al. 2022. Mol Ther Nucleic Acids. 28:87. PubMed
  169. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  170. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  171. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  172. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  173. Bermejo-Jambrina M, et al. 2021. EMBO J. 40:e106765. PubMed
  174. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  175. Koikawa K, et al. 2021. Cell. 184(18):4753-4771.e27. PubMed
  176. Sokol L, et al. 2021. STAR Protocols. 2(2):100489. PubMed
  177. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  178. Troutman TD, et al. 2021. STAR Protocols. 2(1):100363. PubMed
  179. Wang L, et al. 2012. PLoS One. 7:e40056. PubMed
  180. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  181. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  182. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  183. Gomez–Ospina N, et al. 2019. Nat Commun. 3.225694444. PubMed
  184. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  185. Tan S, et al. 2006. J Immunol. 176:2872. PubMed
  186. Roy AG, et al. 2021. Int J Mol Sci. 22:. PubMed
  187. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  188. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  189. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  190. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  191. Babagana M, et al. 2021. Aging (Albany NY). 13:19207. PubMed
  192. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  193. Dungan CM, et al. 2022. Aging Cell. 21:e13528. PubMed
  194. Langhauser F, et al. 2014. Stroke. 45:1799. PubMed
  195. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  196. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  197. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  198. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  199. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  200. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  201. Xiao G, et al. 2018. Cell. 173:470. PubMed
  202. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  203. Wu ZJ, et al. 2018. Int J Oncol. 52:1209. PubMed
  204. Szeifert V, et al. 2021. Front Immunol. 12:671995. PubMed
  205. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  206. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  207. Cao W, et al. 2021. Int J Mol Sci. 22:. PubMed
  208. Calle P, et al. 2021. Cells. 10:. PubMed
  209. Li T, et al. 2021. J Neuroinflammation. 81:18. PubMed
  210. Guo M, et al. 2020. Brain. 1476:143. PubMed
  211. Houben T, et al. 2020. J Pathol. 251:429. PubMed
  212. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  213. Li L, et al. 2014. J Immunol. 192:1034. PubMed
  214. Demers M, et al. 2012. Proc Natl Acad Sci U S A. 109:13076. PubMed
  215. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  216. Zhang T, et al. 2018. PLoS One. 13:e0196571. PubMed
  217. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  218. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  219. Dong Y, et al. 2021. Commun Biol. 4:560. PubMed
  220. Scheiblich H, et al. 2021. Cell. 184:5089. PubMed
  221. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  222. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  223. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  224. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  225. Toyohara T, et al. 2020. Cell Stem Cell. 27:147. PubMed
  226. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  227. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  228. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  229. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  230. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  231. Wang X, et al. 2021. Cell. 184:5357. PubMed
  232. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  233. Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed
  234. Koide S, et al. 2022. iScience. 25:103603. PubMed
  235. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  236. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  237. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  238. Lin KH, et al. 2020. Nat Genet. 52:408. PubMed
  239. Jablonski K, et al. 2015. PLoS One. 10: 0145342. PubMed
  240. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  241. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  242. Resende M, et al. 2013. J Immunol. 191:262. PubMed
  243. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  244. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  245. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  246. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  247. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  248. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  249. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  250. Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
  251. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  252. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  253. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  254. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  255. Avalle L, et al. 2020. Mol Ther Methods Clin Dev. 0.793055556. PubMed
  256. Zhou Q, et al. 2020. Nat Immunol. 1.393055556. PubMed
  257. Schmidt C, et al. 2005. J Immunol. 175:2286. PubMed
  258. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  259. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  260. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  261. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  262. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  263. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  264. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  265. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  266. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  267. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  268. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  269. Baruch K, et al. 2015. EMBO J. 34: 1816 - 1828. PubMed
  270. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  271. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  272. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  273. Zhang M, et al. 2019. Autophagy. 1.423611111. PubMed
  274. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  275. Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed
  276. Gawish R, et al. 2022. Elife. 11:. PubMed
  277. Wang T, et al. 2022. Int J Nanomedicine. 17:2191. PubMed
  278. Hirako N, et al. 2014. PLoS One. 9:103282. PubMed
  279. Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
  280. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  281. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  282. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  283. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  284. Fernando N, et al. 2020. Front Cell Dev Biol. 0.691666667. PubMed
  285. Dougan M, et al. 2018. Cancer Immunol Res. 6:389. PubMed
  286. Abdel Malik R, et al. 2017. Circ Res. 120:99. PubMed
  287. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  288. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  289. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  290. Steinmetz TD, et al. 2021. Autophagy. 17:2238. PubMed
  291. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  292. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  293. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  294. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  295. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
  296. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  297. Wong PP, et al. 2020. Cell. 181(6):1346-1363.e21. PubMed
  298. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  299. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  300. K K, et al. 2016. Haematologica. 151159. PubMed
  301. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
RRID
AB_312790 (BioLegend Cat. No. 101207)
AB_312791 (BioLegend Cat. No. 101208)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 2    Revision Date: 03/14/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse/human CD11b

  • Biotin anti-mouse/human CD11b

  • FITC anti-mouse/human CD11b

  • PE anti-mouse/human CD11b

  • PE/Cyanine5 anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b

  • PE/Cyanine7 anti-mouse/human CD11b

  • Alexa Fluor® 488 anti-mouse/human CD11b

  • Alexa Fluor® 647 anti-mouse/human CD11b

  • Alexa Fluor® 700 anti-mouse/human CD11b

  • Pacific Blue™ anti-mouse/human CD11b

  • APC/Cyanine7 anti-mouse/human CD11b

  • PerCP/Cyanine5.5 anti-mouse/human CD11b

  • PerCP anti-mouse/human CD11b

  • Brilliant Violet 421™ anti-mouse/human CD11b

  • Brilliant Violet 570™ anti-mouse/human CD11b

  • Brilliant Violet 605™ anti-mouse/human CD11b

  • Brilliant Violet 650™ anti-mouse/human CD11b

  • Brilliant Violet 711™ anti-mouse/human CD11b

  • Brilliant Violet 785™ anti-mouse/human CD11b

  • Brilliant Violet 510™ anti-mouse/human CD11b

  • Ultra-LEAF™ Purified anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse/human CD11b

  • PE/Dazzle™ 594 anti-mouse/human CD11b

  • APC/Fire™ 750 anti-mouse/human CD11b

  • TotalSeq™-A0014 anti-mouse/human CD11b

  • Brilliant Violet 750™ anti-mouse/human CD11b

  • TotalSeq™-B0014 anti-mouse/human CD11b

  • TotalSeq™-C0014 anti-mouse/human CD11b

  • Spark NIR™ 685 anti-mouse/human CD11b

  • PE/Fire™ 640 anti-mouse/human CD11b

  • Spark YG™ 593 anti-mouse/human CD11b

  • Spark YG™ 570 anti-mouse/human CD11b

  • PE/Fire™ 810 anti-mouse/human CD11b

  • APC/Fire™ 810 anti-mouse/human CD11b Antibody

  • Spark Blue™ 550 anti-mouse/human CD11b

  • Spark UV™ 387 anti-mouse/human CD11b
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account